We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a provider of on-demand and off-the-shelf European reimbursement analysis and strategy for industry and investment companies

News and blog posts

Stay up-to-date about developments of reimbursement systems in Europe

06 Dec 2017
The Institute for Quality and Efficiency in Health Care (IQWiG), in agreement with the relevant manufacturers' associations, has drafted a model contract to regulate the conditions under which information provided by manufacturers for the evaluation of medical devices is used by IQWiG and made available to third parties.


Mar 2018

Interstitial low-dose rate brachytherapy was commissioned to the Institute for Quality and Efficiency in Health Care (IQWiG) by the Federal Joint Committee (G-BA) in order to analyze the current knowledge on procedure.


Mar 2018

The Institute for Quality and Efficiency in Health Care (IQWiG) released the final report on the assessment of benefit for telemonitoring of cardiac implantable electronic devices compared to a standard treatment without telemonitoring in patients with ventricular tachyarrhythmias and / or heart failure. It was concluded that the benefits of the telemonitoring for patients with cardiac failure or heart rhythm disorders with a fast heart rate remain unclear.


Mar 2018

In the first half of March, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedures Guidance (laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina and mosaicplasty for symptomatic articular cartilage defects of the knee) and one new Technology appraisal guidance for autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee.


Mar 2018

In January 2018, the Galician HTA body, Avalia-T, released the technical review of The Vivistim® system, an implantable device for upper-limb rehabilitation after stroke. Evidence was found to be very limited to advice on the implementation of the technology.

About us

We are a group of enthusiasts who are passionate about the areas of health policy, evidence generation, reimbursement and funding for medical technologies. We have turned our passion into a career. More specifically, we develop insights which help our customers optimize their business decisions

Our company is based in Stockholm, Sweden

The founder of company is Oleg Borisenko, one of the leading experts on European market access for medical devices. With more than 12 years of experience in the field, Oleg has led several hundred of projects. These include reimbursement analyses and strategies, value dossiers, health economic models and evidence generation strategies

Our team consists of eight clinical coders and market analysts, including five medical doctors and one pharmacist. Three of our members have PhD degrees in different areas of clinical and public health science

Our unique proposition is Pan-European reimbursement mapping and strategy projects for the Med Tech and IVD industries. To match the requirements and budget of our various customers, we approach their needs differently: from low-cost off-the-shelf reimbursement reports for dozens of medical technologies to full scale reimbursement and evidence generation projects

We provide analyses for 14 European countries

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • Transcatheter aortic valve implantation (TAVI) 
  • Eight minimally invasive and transcatheter mitral valve repair and replacement technologies
  • Group of peripheral vascular arterial interventions (angioplasty, angioplasty using drug-eluting balloon, stenting using bare metal and drug-eluting stents, atherectomy, periperal IVUS)
  • Robotic surgery interventions
  • Peripheral venous interventions for deep vein thrombosis and venous insufficiency
  • Coronary percutaneous revascularization (angioplasty using plain and drug-coated balloon, bare metal and drug-eluting stents, mechanical thrombectomy, percutaneous atherectomy)
  • Coronary percutaneous imaging procedures (angiography, IVUS, FFR, OCT)
  • Mechanical thrombectomy for stroke
  • Ablation of heart tissue for atrial fibrillation

Ongoing reports:

  • Radiotherapy procedures (all types)
  • Procedures on spine for intervertebral disc prolapse, vertebra fracture
  • Interventional procedure for gastro-esophageal reflux disease